What Is the Program?
How the Program Works
Who We Are
News & Resources
Contact

Menu

What Is the Program?
How the Program Works
Who We Are
News & Resources
Contact

Search

Search

Close this search box.

MDA Preferred Practices (French version)

September 30, 2016
Français, Resources and Tools
Français

Un guide pratique fondé sur des preuves pour un programme d’administration traitement de masse efficace. ENVISION, September 2016.

mda_preferred_practices-french|mda_preferred_practices-french

Share This Post:

Facebook

Twitter

LinkedIn

Email

Print

Get Our Newsletter

Sign up for quarterly updates and breaking news

Name(Required)

Email(Required)

Please select your preferred language:(Required)

English

Français

Δ

The Mectizan Donation Program is an international program to eliminate river blindness and lymphatic filariasis (LF), primarily funded by Merck & Co., Inc., Rahway, N.J., U.S.A.,* with additional support from GSK. For LF, Mectizan® is co-administered with albendazole, which is donated by GSK. | *Merck is known as MSD outside the USA and Canada.

Get in Touch

mectizan@taskforce.org
Tel. 1-404-371-1460
Fax 1-404-371-1138
330 West Ponce de Leon Avenue | Decatur, Georgia 30030 | USA

What Is The Program?

Overview
History Of The Program
Lymphatic Filariasis
River Blindness
The Medicines
Where We Work

Quick Links

How the Program Works
News from MDP
Resources
Meet Our Partners
Disclaimer
Contact Us

Facebook Instagram Twitter Vimeo

© 2023 Mectizan Donation Program ®

See the Annual Highlights of 2022—our accomplishments of the past year and plans for the future.